Published in Vaccine Weekly, August 14th, 1995
Rhesus macaques develop an AIDS-like disease after infection with SIV. This SIV-macaque model is most reliable and widely use for AIDS pathogenesis and vaccine studies. Several researchers have successfully prevented the experimental SIV infection of macaques with candidate vaccines, but any clear correlation between the induction of humoral or cell-mediated immunity (CMI) and protection against an experimental infection has not been elucidated.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.